BioAtla (BCAB) Depreciation & Amortization (CF) (2020 - 2026)

BioAtla's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $120000.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 34.43% year-over-year to $120000.0 in Q1 2026; TTM through Mar 2026 was $310000.0, a 64.29% decrease from a year earlier, with the FY2025 full-year figure at $373000.0, down 59.68% from the prior year.
• Depreciation & Amortization (CF) rose to $120000.0 in Q1 2026 per BCAB's latest filing, from $19000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $368000.0 in Q4 2023 and bottomed at $19000.0 in Q4 2025.
• The 5-year median for Depreciation & Amortization (CF) is $240000.0 (2024), against an average of $225764.7.
• Across the five-year window, Depreciation & Amortization (CF) climbed 23.49% in 2023 and plunged 91.67% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $298000.0 in 2022, then increased by 23.49% to $368000.0 in 2023, then slumped by 38.04% to $228000.0 in 2024, then plunged by 91.67% to $19000.0 in 2025, then soared by 531.58% to $120000.0 in 2026.
• Per Business Quant, the three latest BCAB Depreciation & Amortization (CF) figures stand at $120000.0 (Q1 2026), $19000.0 (Q4 2025), and $56000.0 (Q3 2025).